
CHMP Grants Positive Opinion to Tislelizumab/Chemo in Front-Line ES-SCLC
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approval for tislelizumab-jsgr (Tevimbra) combined with etoposide and platinum chemotherapy in the first-line treatment of adult patients with …